Alcohol and Hepatocarcinogenesis

Overview

Journal Clin Mol Hepatol

Specialty Gastroenterology

Date 2020 Oct 15

PMID 33053943

Citations 29

Authors

Makiko Taniai

Affiliations

Soon will be listed here.

Abstract

An excessive alcohol intake may result in fatty liver, acute/chronic hepatitis, cirrhosis, and lead to hepatocellular carcinoma (HCC). The aim of this review is to clarify the present condition and the mechanisms of alcohol-related hepatocarcinogenesis and clinical risk factors for alcohol-related HCC. There are several possible mechanisms through which alcohol may induce hepatocarcinogenesis, including the mutagenic effects of acetaldehyde toxicity through the formation of protein and DNA adducts and the production of reactive oxygen species due to the excessive hepatic deposition of iron, changes to lipid peroxidation and metabolism, inflammation and an impaired immune response and modifications to DNA methylation. Furthermore, it has been reported that alcohol accelerates liver carcinogenesis through several signaling pathways including gut-liver axis. From a clinical perspective, it is well known that alcohol interacts with other factors, such as age, gender, viral hepatitis, obesity, and diabetes leading to an increased risk of HCC.

Citing Articles

Application of nanotechnology in the treatment of hepatocellular carcinoma.

Cai L, Du Y, Xiong H, Zheng H Front Pharmacol. 2024; 15:1438819.

PMID: 39679376 PMC: 11637861. DOI: 10.3389/fphar.2024.1438819.

A nonlinear relationship between alcohol consumption and cognitive function in elderly people: a population-based study from NHANES 2011-2014.

Chen K, Li Y, Yue R, Jin Z, Cui S, Zhang X Front Aging Neurosci. 2024; 16:1458274.

PMID: 39654808 PMC: 11626387. DOI: 10.3389/fnagi.2024.1458274.

ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation.

Song L, Huang S, Yan H, Ma Q, Luo Q, Qiu J Front Pharmacol. 2024; 15:1423031.

PMID: 39640486 PMC: 11617210. DOI: 10.3389/fphar.2024.1423031.

Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application.

Su L, Bu J, Yu J, Jin M, Meng G, Zhu X Clin Transl Med. 2024; 14(11):e70066.

PMID: 39462685 PMC: 11513202. DOI: 10.1002/ctm2.70066.

Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification.

Song B, Kim A, Goh M, Kang W, Gwak G, Paik Y Liver Cancer. 2024; 13(5):561-571.

PMID: 39435269 PMC: 11493391. DOI: 10.1159/000538301.

References

Mandayam S, Jamal M, Morgan T . Epidemiology of alcoholic liver disease. Semin Liver Dis. 2004; 24(3):217-32. DOI: 10.1055/s-2004-832936. View

Hassan M, Hwang L, Hatten C, Swaim M, Li D, Abbruzzese J . Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002; 36(5):1206-13. DOI: 10.1053/jhep.2002.36780. View

Hlady R, Tiedemann R, Puszyk W, Zendejas I, Roberts L, Choi J . Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis. Oncotarget. 2014; 5(19):9425-43. PMC: 4253444. DOI: 10.18632/oncotarget.2444. View

Chiba T, Marusawa H, Ushijima T . Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012; 143(3):550-563. DOI: 10.1053/j.gastro.2012.07.009. View

Seitz H, Becker P . Alcohol metabolism and cancer risk. Alcohol Res Health. 2007; 30(1):38-41, 44-7. PMC: 3860434. View

Goldar S, Shekari Khaniani M, Mansoori Derakhshan S, Baradaran B . Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev. 2015; 16(6):2129-44. DOI: 10.7314/apjcp.2015.16.6.2129. View

Roberts L, Sirlin C, Zaiem F, Almasri J, Prokop L, Heimbach J . Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. Hepatology. 2017; 67(1):401-421. DOI: 10.1002/hep.29487. View

Salaspuro M . Acetaldehyde: a cumulative carcinogen in humans. Addiction. 2009; 104(4):551-3. DOI: 10.1111/j.1360-0443.2009.02546.x. View

BARAONA E, Abittan C, Dohmen K, Moretti M, Pozzato G, CHAYES Z . Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res. 2001; 25(4):502-7. View

10.

Matsushita H, Takaki A . Alcohol and hepatocellular carcinoma. BMJ Open Gastroenterol. 2019; 6(1):e000260. PMC: 6505979. DOI: 10.1136/bmjgast-2018-000260. View

11.

Ramadori P, Cubero F, Liedtke C, Trautwein C, Nevzorova Y . Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame. Cancers (Basel). 2017; 9(10). PMC: 5664069. DOI: 10.3390/cancers9100130. View

12.

Torre L, Bray F, Siegel R, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2):87-108. DOI: 10.3322/caac.21262. View

13.

Sarsour E, Kumar M, Chaudhuri L, Kalen A, Goswami P . Redox control of the cell cycle in health and disease. Antioxid Redox Signal. 2009; 11(12):2985-3011. PMC: 2783918. DOI: 10.1089/ars.2009.2513. View

14.

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

15.

Zhong J, You X, Gong W, Ma L, Zhang Y, Mo Q . Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis. PLoS One. 2012; 7(3):e32159. PMC: 3293888. DOI: 10.1371/journal.pone.0032159. View

16.

Hagymasi K, Blazovics A, Lengyel G, Kocsis I, Feher J . Oxidative damage in alcoholic liver disease. Eur J Gastroenterol Hepatol. 2001; 13(1):49-53. DOI: 10.1097/00042737-200101000-00009. View

17.

Jin F, Qu L, Shen X . Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis. J Exp Clin Cancer Res. 2010; 29:18. PMC: 2845109. DOI: 10.1186/1756-9966-29-18. View

18.

Ganne-Carrie N, Nahon P . Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol. 2019; 70(2):284-293. DOI: 10.1016/j.jhep.2018.10.008. View

19.

Brandon-Warner E, Walling T, Schrum L, McKillop I . Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res. 2011; 36(4):641-53. PMC: 3288433. DOI: 10.1111/j.1530-0277.2011.01660.x. View

20.

Ferrere G, Wrzosek L, Cailleux F, Turpin W, Puchois V, Spatz M . Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J Hepatol. 2016; 66(4):806-815. DOI: 10.1016/j.jhep.2016.11.008. View